Boston Scientific Subsidiaries Barred From Selling Multiple Drug-Eluting Stent Lines In Germany

A German court had previously blocked Boston Scientific’s German subsidiary from selling drug-eluting stents affected by OrbusNeich’s patent suit; the new injunction closes a loophole, preventing any Boston Scientific subsidiary from selling the devices in Germany.